← Back to Search

Behavioural Intervention

TMS for MTBI-related Headaches

San Diego, CA
N/A
Waitlist Available
Led By Albert Yick Leung, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the measure will be assessed at the baseline visit, 1-week, 1-month, 2-month and 3-month post-treatment follow up visits.

Summary

This trial is testing whether a treatment called repetitive transcranial magnetic stimulation (rTMS) can help reduce headaches in military personnel with mild traumatic brain injury (MTBI).

See full description
Who is the study for?
This trial is for military personnel with mild traumatic brain injury (MTBI) who suffer from persistent headaches. Participants must have experienced symptoms like feeling dazed or confused, and a loss of consciousness for less than 30 minutes after the injury. They should not have had chronic headaches before the MTBI or any experience with TMS treatment. Those with pacemakers, metal in their body, history of seizures, major psychiatric diseases, or active substance dependence cannot join.
What is being tested?
The study tests if repetitive transcranial magnetic stimulation (rTMS) can manage headaches caused by MTBI over a period of 2-3 months. It compares the effects of actual rTMS treatment to sham (fake) rTMS to see which is more effective at reducing headache intensity and frequency.See study design
What are the potential side effects?
While not explicitly stated here, common side effects of rTMS may include discomfort at the site on the head where the magnet is placed during treatment, lightheadedness, temporary hearing issues due to noise during session, and in rare cases could induce seizures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the measure will be assessed at the baseline visit, 1-week, 1-month, 2-month and 3-month post-treatment follow up visits.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the measure will be assessed at the baseline visit, 1-week, 1-month, 2-month and 3-month post-treatment follow up visits. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from Baseline to Post-Treatment Depression scores
Change from Baseline to Post-Treatment Executive Functioning
Change from Baseline to Post-Treatment Global Pain scores.
+5 more
Secondary study objectives
Explore the treatment effect on the pain related network of the brain

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Transcranial Magnetic StimulationExperimental Treatment2 Interventions
Active-repetitive transcranial magnetic stimulation (rTMS) at the left motor cortex.
Group II: Sham Transcranial Magnetic StimulationPlacebo Group2 Interventions
Sham rTMS will consist of the same parameters as active, however, the subject will not receive the actual magnetic stimulation to the left motor cortex.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Magnetic resonance imaging (MRI)
2019
Completed Phase 4
~1480
Transcranial Magnetic Stimulation
2017
Completed Phase 4
~730

Find a Location

Closest Location:VA San Diego Healthcare System, San Diego, CA· San Diego, CA· 1955 miles

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,686 Previous Clinical Trials
3,758,539 Total Patients Enrolled
Albert Yick Leung, MDPrincipal InvestigatorVA San Diego Healthcare System, San Diego, CA
2 Previous Clinical Trials
137 Total Patients Enrolled

Media Library

rTMS (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03314584 — N/A
Traumatic Brain Injury Research Study Groups: Sham Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation
Traumatic Brain Injury Clinical Trial 2023: rTMS Highlights & Side Effects. Trial Name: NCT03314584 — N/A
rTMS (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03314584 — N/A
~22 spots leftby Mar 2026